Molina Healthcare (MOH)
(Delayed Data from NYSE)
$306.00 USD
-3.30 (-1.07%)
Updated Nov 14, 2024 04:00 PM ET
After-Market: $306.03 +0.03 (0.01%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$306.00 USD
-3.30 (-1.07%)
Updated Nov 14, 2024 04:00 PM ET
After-Market: $306.03 +0.03 (0.01%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth B Momentum A VGM
Zacks News
UnitedHealth Group (UNH) to Expand Coverage Area in 2024
by Zacks Equity Research
UnitedHealth Group (UNH) is set to enhance its offerings with UCard and expand to 110 new counties in 2024 with its Individual Medicare Advantage Plan.
Here's Why Molina (MOH) is a Strong Growth Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Should Value Investors Buy Molina Healthcare (MOH) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
The Zacks Analyst Blog Highlights Molina Healthcare, Dr. Reddy's Laboratories and NeuroBo Pharmaceuticals
by Zacks Equity Research
Molina Healthcare, Dr. Reddy's Laboratories and NeuroBo Pharmaceuticals are part of the Zacks top Analyst Blog.
4 Stocks That Stand Out on Attractive Interest Coverage Ratio
by Sumit Singh
A company that is capable of generating earnings well above its interest expense can withstand financial hardship. MOD, SFM, MOH and MCK are sound enough to meet financial obligations.
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Want to Shrug Off Volatility? Buy 3 Medical Growth Stocks
by Indrajit Bandyopadhyay
We pick three medical stocks - MOH, RDY and NRBO - that have gained more than 5% in the past three months amid market volatility.
Is Alcon (ALC) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Here is how Alcon (ALC) and Molina (MOH) have performed compared to their sector so far this year.
If You Invested $1000 in Molina a Decade Ago, This is How Much It'd Be Worth Now
by Zacks Equity Research
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
Are Investors Undervaluing Molina Healthcare (MOH) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here's Why Molina (MOH) is a Strong Value Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Add These 4 Stocks With Remarkable Interest Coverage Ratio
by Sumit Singh
A company that is capable of generating earnings well above its interest expense can withstand financial hardship. STRL, SFM, MOH and MCK are sound enough to meet financial obligations.
Why Molina (MOH) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why You Should Retain Centene (CNC) in Your Portfolio
by Zacks Equity Research
Strong growth in membership, contract wins, accretive acquisitions and streamlining of businesses poise Centene (CNC) well for growth.
Community Health (CYH), Mindoula to Offer Mental Health Care
by Zacks Equity Research
Community Health (CYH) collaborates with Mindoula to enhance the availability of behavioral health resources to its affiliated provider network, who can now treat patients better.
3 Reasons Growth Investors Will Love Molina (MOH)
by Zacks Equity Research
Molina (MOH) could produce exceptional returns because of its solid growth attributes.
Molina Healthcare (MOH) Closes $150M My Choice Wisconsin Buyout
by Zacks Equity Research
Molina Healthcare (MOH) completes the My Choice Wisconsin acquisition ahead of the updated scheduled time.
Factors That Make Molina Healthcare (MOH) an Attractive Bet Now
by Zacks Equity Research
Molina Healthcare (MOH) remains well-poised for growth on a growing customer base, acquisitions and solid cash reserves.
Humana (HUM) Down 5.2% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Humana (HUM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why Investors Should Hold Humana (HUM) in Portfolio
by Zacks Equity Research
Humana (HUM) remains well-poised for growth on the back of an expanding Medicare Advantage membership, upgraded health plan offering suite and solid cash reserves.
HCA Healthcare (HCA) & Google Cloud Unite to Improve Efficiency
by Zacks Equity Research
HCA Healthcare (HCA) partners with Google Cloud to improve and automate workflows.
Is Molina Healthcare (MOH) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks.com featured highlights include Sprouts Farmers Market, Molina Healthcare, Atmos Energy and McKesson
by Zacks Equity Research
Sprouts Farmers Market, Molina Healthcare, Atmos Energy and McKesson are part of the Zacks Screen of the Week article.
5 HMO Stocks to Watch Amid Growing Premiums & Membership
by Debasmita Chatterjee
Expanding customer base, contract wins and a rapidly growing aging U.S. population will likely drive the performances of the Zacks Medical-HMO industry players. UNH, CI, HUM, CNC and MOH are poised to benefit from favorable industry trends.
Bet on These 4 Stocks With Exciting Interest Coverage Ratio
by Sumit Singh
A company capable of generating earnings well above its interest expense can withstand financial hardship. SFM, MOH, ATO and MCK are strong enough to meet financial obligations.